Company Overview
Snapshot
Founded in May 2019 by Guy Yachin, Xerient operates with 1–10 employees. The company has raised $5.03M across 3 funding rounds from 2 investors.
Business overview
Xerient is a Health Tech & Life Sciences company focused on addressing unmet needs in cancer treatment, particularly within abdominal and gastrointestinal cancers. The company develops novel therapeutics and diagnostic technologies aimed at dramatically improving patient survival. Xerient is introducing a portfolio of products to tackle hard-to-treat cancers in the abdominal/GI area, with an initial focus on solutions for pancreatic cancer.
Log in to access full profile ›Company Intelligence Q&A
- When was Xerient founded?
- Xerient was founded in May 2019 by Guy Yachin.
- What is Xerient's primary focus in cancer treatment?
- Xerient is focused on developing novel therapeutics and diagnostic technologies for abdominal and gastrointestinal cancers, starting with pancreatic cancer, to improve patient survival.